COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,585 Articles (22,905 medRxiv, 8,680 bioRxiv)

Most recent first Previous |  Page 1271: Articles 12701-12710  | Next

Spatiotemporal analyses illuminate the competitive advantage of a SARS-CoV-2 variant of concern over a variant of interest
Russell, A., O'Connor, C., Lasek-Nesselquist, E., Plitnick, J., Kelly, J. P., Lamson, D. M., St George, K.
10.1101/2021.09.14.21262977 — Posted: 2021-09-20
Quantitative measurement of infectious virus in SARS-CoV-2 Alpha, Delta and Epsilon variants reveals higher infectivity (viral titer:RNA ratio) in clinical samples containing the Delta and Epsilon variants.
Despres, H. W., Mills, M. G., Shirley, D. J., Schmidt, M. M., Huang, M.-L., Jerome, K. R., Greninger, A. L., Bruce, E. A.
10.1101/2021.09.07.21263229 — Posted: 2021-09-20 Discussion: Offsite
Self-reported and physiological reactions to the third BNT162b2 mRNA COVID-19 (booster) vaccine dose
Mofaz, M., Yechezkel, M., Guan, G., L. Brandeau, M., Patalon, T., Gazit, S., Yamin, D., Shmueli, E.
10.1101/2021.09.15.21263633 — Posted: 2021-09-20
Detection of SARS-CoV-2 in the community by nucleic acid amplification testing of saliva
Fronza, F., Groff, N., Martinelli, A., Passerini, B. Z., Rensi, N., Cortelletti, I., Vivori, N., Adami, V., Helander, A., Bridi, S., Pancher, M., Greco, V., Garritano, S. I., Piffer, E., Stefani, L., De Sanctis, V., Bertorelli, R., Pancheri, S., Collini, L., Quattrone, A., Capobianchi, M. R., Icardi, G., Poli, G., Caciagli, P., Ferro, A., Pizzato, M.
10.1101/2021.09.15.21263644 — Posted: 2021-09-20
Distributed Counterfactual Modeling Approach for Investigating Hospital-Associated Racial Disparities in COVID-19 Mortality
Edmondson, M. J., Luo, C., Islam, N., Asch, D., Bian, J. J., Chen, Y.
10.1101/2021.09.14.21263596 — Posted: 2021-09-20
Sex differences in cardio-pulmonary pathology of SARS-CoV2 infected and Trypanosoma cruzi co-infected mice
Dhanyalayam, D., Lizardo, K., Oswal, N., Thangavel, H., Dolgov, E., Perlin, D. S., Nagajyothi, J. F.
10.1101/2021.09.18.460895 — Posted: 2021-09-18
Copper(II) Gluconate Boosts the Anti-SARS-CoV-2 Effect of Disulfiram in Vitro
Xu, L., Xu, W., Zhao, S., Zhao, S., Lu, L., Lin, B.-L.
10.1101/2021.09.17.460613 — Posted: 2021-09-18 Discussion: Onsite
Genetically diverse mouse models of SARS-CoV-2 infection model clinical variation and cytokine responses in COVID-19
Robertson, S., Bedard, O., McNally, K., Lewis, M., Clancy, C., Shaia, C., Broeckel, R., Chiramel, A., Sturdevant, G., Forte, E., Preuss, C., Baker, C., Sturdevant, D., Martens, C., Holland, S., Rosenthal, N., Best, S.
10.1101/2021.09.17.460664 — Posted: 2021-09-18
3D virtual Histopathology of Cardiac Tissue from Covid-19 Patients based on Phase-Contrast X-ray Tomography
Reichardt, M., Moller Jensen, P., Andersen Dahl, V., Bjorholm Dahl, A., Ackermann, M., Shah, H., Länger, F., Werlein, C., Kuehnel, M. P., Jonigk, D., Salditt, T.
10.1101/2021.09.16.460594 — Posted: 2021-09-18
Altered fibrin clot structure contributes to thrombosis risk in severe COVID-19
Wygrecka, M., Birnhuber, A., Seeliger, B., Michalick, L., Pak, O., Schultz, A.-S., Schramm, F., Zacharias, M., Gorkiewicz, G., David, S., Welte, T., Schmidt, J. J., Weissmann, N., Schermuly, R. T., Barreto, G., Schäfer, L., Markart, P., Brack, M. C., Hippenstiel, S., Kurth, F., Sander, L. E., Witzenrath, M., Kuebler, W. M., Kwapiszewska, G., Preissner, K. T.
10.1101/2021.09.17.460777 — Posted: 2021-09-18

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).